-transparent.png){kind=logo}
Five patients with neuropathy and IgM M-proteins that reacted with myelin-associated glycoprotein (MAG) were treated for 10 to 20 months with cytostatic agents. In 2 patients, a decrease in serum M-protein and in anti-MAG IgM levels coincided with a progressive improvement of neuropathy. No clinical improvement and no decrease of anti-MAG IgM were observed in the other patients. The close relationship between the decrease of anti-MAG M-proteins and clinical improvement in these patients supports the pathogenetic role of the M-protein in the neuropathy.
Related Publications
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
July 1983,
Neurology,
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
January 2001,
Neurology,
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
February 1987,
Neurology,
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
November 2020,
Blood,
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
June 2023,
Journal of the peripheral nervous system : JPNS,
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
February 2015,
Neuroscience research,
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
August 1985,
Annals of neurology,
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
June 1983,
Journal of immunology (Baltimore, Md. : 1950),
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
June 2015,
Annals of hematology,
E Nobile-Orazio, and
L Baldini, and
S Barbieri, and
P Marmiroli, and
G Spagnol, and
E Francomano, and
G Scarlato
March 2010,
Current treatment options in neurology,
